Linero Itali M, Doncel Adriana, Chaparro Orlando
Grupo de Investigación Biología de Células Madre, Universidad Nacional de Colombia, Bogotá, D.C, Colombia.
Biomedica. 2014 Jan-Mar;34(1):67-78. doi: 10.1590/S0120-41572014000100010.
The use of mesenchymal stem cells in clinical practice has increased considerably in the last decade because they play a supporting role in the processes of tissue repair and regeneration, becoming the main tool of cell therapy for the treatment of diseases functionally affecting bone and cartilage tissue .
To evaluate in vitro the proliferative and osteogenic differentiation ability of mesenchymal stem cells derived from human adipose tissue in a blood plasma hydrogel.
Mesenchymal stem cells were obtained from human adipose tissue explants and characterized by flow cytometry. Their multipotentiality was demonstrated by their ability to differentiate to adipogenic and osteogenic lineages. Cell proliferation and osteogenic differentiation ability of the cells cultured in blood plasma hydrogels were also evaluated.
Mesenchymal stem cells derived from human adipose tissue growing in human blood plasma hydrogels showed a pattern of proliferation similar to that of the cells cultured in monolayer and also maintained their ability to differentiate to osteogenic lineage.
Human blood plasma hydrogels are a suitable support for proliferation and osteogenic differentiation of mesenchymal stem cells derived from human adipose tissue and provides a substrate that is autologous, biocompatible, reabsorbable, easy to use, potentially injectable and economic, which could be used as a successful strategy for the management and clinical application of cell therapy in regenerative medicine.
在过去十年中,间充质干细胞在临床实践中的应用显著增加,因为它们在组织修复和再生过程中发挥支持作用,成为治疗功能性影响骨和软骨组织疾病的细胞治疗的主要工具。
在体外评估人血浆水凝胶中来源于人脂肪组织的间充质干细胞的增殖和成骨分化能力。
从人脂肪组织外植体中获取间充质干细胞,并通过流式细胞术进行表征。通过其向脂肪生成和成骨谱系分化的能力证明其多能性。还评估了在人血浆水凝胶中培养的细胞的增殖和成骨分化能力。
在人血浆水凝胶中生长的来源于人脂肪组织的间充质干细胞显示出与单层培养细胞相似的增殖模式,并且还保持了其向成骨谱系分化的能力。
人血浆水凝胶是来源于人脂肪组织的间充质干细胞增殖和成骨分化的合适支持物,并提供了一种自体、生物相容性、可再吸收、易于使用、潜在可注射且经济的基质,可作为再生医学中细胞治疗管理和临床应用的成功策略。